Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008)

Pathology
Jan M BellRonald N Jones

Abstract

To assess in vitro activity and spectrum of daptomycin, a new lipopeptide antimicrobial, against contemporary isolates of Gram positive pathogens in Australia and New Zealand in 2008. Gram positive isolates from patients with a range of bacterial infections served by seven Australian and three New Zealand laboratories were tested by broth microdilution and susceptibility results interpreted using current Clinical and Laboratory Standards Institute (CLSI) standards against daptomycin and a range of comparator agents including oxacillin, vancomycin and linezolid. 872 Staphylococcus aureus (24.0% oxacillin resistant; Australia 28.4%, New Zealand 9.0%), 60 coagulase negative staphylococci (83.3% oxacillin resistant), 113 Enterococcus species (6.2% vancomycin non-susceptible), 40 viridans group Streptococcus species (7.5% penicillin resistant), and 158 beta-haemolytic Streptococcus species were tested. Daptomycin was active against all 1243 strains, and no resistance or reduced susceptibility was detected, including among multi-resistant strains and those resistant to vancomycin. At the time of the introduction of daptomycin into clinical practice in Australia and New Zealand, this agent retains full activity and holds promise as an...Continue Reading

References

Aug 18, 2006·The New England Journal of Medicine·Vance G FowlerUNKNOWN S. aureus Endocarditis and Bacteremia Study Group
Aug 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W Boucher, George Sakoulas
Oct 18, 2007·Pharmacology·Robert SauermannChristian Joukhadar
Oct 31, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cesar A AriasBarbara E Murray
Mar 24, 2009·Current Opinion in Chemical Biology·Richard H Baltz

❮ Previous
Next ❯

Citations

May 21, 2013·International Journal of Antimicrobial Agents·Rachel L SoonJack Brown
Jul 13, 2011·Pacing and Clinical Electrophysiology : PACE·Ahmad F JebranFriedrich A Schoendube
May 29, 2015·Therapeutic Drug Monitoring·Eliane Gandolpho TótoliHérida Regina Nunes Salgado
Mar 6, 2012·Biochimica Et Biophysica Acta·Jawad K Muraih, Michael Palmer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Chung-Chih LaiShan-Chwen Chang
The Journal of Antimicrobial Chemotherapy
Rafael CantónAlan P Johnson
Biochimica Et Biophysica Acta
Jawad K MuraihMichael Palmer
© 2021 Meta ULC. All rights reserved